Market Overview The Thalassemia Market critically depends on iron chelation therapy as chronic transfusion inevitably causes progressive iron overload threatening cardiac, hepatic, and endocrine function. Effective chelation has transformed thalassemia major from a fatal childhood disease to a manageable chronic condition. The chelation segment encompasses deferoxamine, deferasirox, and...